Results 101 to 110 of about 113,934,450 (165)

Circulating ACE2 levels and ACE I/D polymorphism in severe aortic stenosis. [PDF]

Sci Rep
Mercean DB, Budişan L, Pop LA, Berindan-Neagoe I, Pop D, Şerban AM, Melincovici CS, Mihu CM.   +7 more
europepmc   +1 more source

Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE Inhibitor. [PDF]

Hypertension
Fischer R, Wysocki J, Hassler L, Batlle D.   +3 more
europepmc   +1 more source

Alzheimer's disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II. [PDF]

J Biol Chem
Salvo MA, Cuddy LK, Prokopenko D, Watkins E, Tanzi RE, Vassar R.   +5 more
europepmc   +1 more source

Molecular war and peace: the concurrent path to antibiosis and antibiotic resistance. [PDF]

Front Microbiol
Baquero F, Cantón R, Herencias C, Gama JA, Coque TM.   +4 more
europepmc   +1 more source

Angiotensin II and angiotensin converting enzyme: key players in the pathogenesis of hypertensive retinopathy. [PDF]

Rom J Ophthalmol
Pavlovschi E, Pantea V, Borovic D, Tagadiuc O.   +3 more
europepmc   +1 more source

Renin-angiotensin imbalance promotes excessive fibrin deposition through M2 macrophage-derived tissue factor expression in eosinophilic chronic rhinosinusitis. [PDF]

Inflamm Res
Takabayashi T, Yoshida K, Kato Y, Sakashita M, Fujieda S.   +4 more
europepmc   +1 more source

Angiotensin-converting enzyme overexpression in mouse neutrophils prevents Alzheimer's-like cognitive decline. [PDF]

Front Immunol
Shibata T, Bhat SA, Cao D, Saito S, Bernstein EA, Okwan-Duodu D, Tourtellotte WG, Bernstein KE, Khan Z.   +8 more
europepmc   +1 more source

Is long-term disruption of the renin-angiotensin-aldosterone system associated with long COVID? A retrospective cohort study among healthcare workers. [PDF]

BMC Infect Dis
Lange-Tal T, Tuvia N, Lazar S, Farajh Y, Bernstine T, Abassi Z, Edelstein M, Jabal KA.   +7 more
europepmc   +1 more source

Vascular Immune Crosstalk in COVID-19: RAAS Biomarker Signature Linking Angiotensin II to Respiratory Compromise and Soluble ACE2 to IL-13 and FGF, Revealing Therapeutic Targets. [PDF]

Int J Mol Sci
Fernandes TFB, Araujo IL, Vianna PHO, Bonomo AC, Pilotto JH, Côrtes FH, Morgado MG, Giacoia-Gripp CBW, De Sá NBR, Ribeiro-Alves M, Ribeiro MPD, Cardoso SW, Veloso VG, Grinsztejn B, Saraiva RM, De Almeida DV.   +15 more
europepmc   +1 more source